Abionic
Founded 2010 · 30 employees on LinkedIn · 1 known investors
Abionic develops the abioSCOPE, a near-patient rapid diagnostic platform that uses nanofluidic immunoassay technology to deliver lab-quality results from a single drop of blood within minutes. The platform is designed for clinical settings including hospitals and laboratories to enable early detection of conditions such as sepsis.
Founders & leadership
Abionic was founded in 2010 by Iwan Märki and Nicolas Durand.
Investors · 1
Frequently asked questions
- What does Abionic do?
- Abionic develops the abioSCOPE, a near-patient rapid diagnostic platform that uses nanofluidic immunoassay technology to deliver lab-quality results from a single drop of blood within minutes. The platform is designed for clinical settings including hospitals and laboratories to enable early detection of conditions such as sepsis.
- Who founded Abionic?
- Abionic was founded by Iwan Märki, Nicolas Durand in 2010.
- Who are Abionic's investors?
- Abionic's investors include Polytech Ecosystem Ventures.